Table 1.
Characteristics | All (n = 289) | Confirmed LNTB (n = 61) | Probable LNTB (n = 192) | Non-LNTB (n = 36) |
---|---|---|---|---|
Age (year, mean ± SD) | 39.7±19.0 | 47.7±20.7 | 36.4±16.4 | 44.8±23.1 |
Male (n, %) | 127 (43.9) | 25 (41.0) | 81 (42.2) | 21 (58.3) |
HIV positive (n, %) | 1 (0.3) | 1 (1.6) | 0 (0.0) | 0 (0.0) |
Symptoms (n, %) | ||||
Fever | 76 (26.3) | 19 (31.1) | 49 (25.5) | 8 (22.2) |
Night sweat | 40 (13.8) | 17 (27.9) | 21 (10.9) | 2 (5.6) |
Pain | 74 (25.6) | 21 (34.4) | 32 (16.7) | 21 (58.3) |
Dysphagia | 9 (3.1) | 4 (6.6) | 3 (1.6) | 2 (5.6) |
Weigh loss | 38 (13.1) | 19 (31.1) | 17 (8.9) | 2 (5.6) |
LN sites (n, %) | ||||
Cervical LN | 264 (91.3) | 57 (93.4) | 174 (90.6) | 33 (91.7) |
Axillary LN | 23 (8.0) | 4 (6.6) | 16 (8.3) | 3 (8.3) |
Inguinal LN | 2 (0.7) | 0 (0.0) | 2 (1.0) | 0 (0.0) |
Other sites involved of TB (n, %) | ||||
Pulmonary TB | 122 (42.2) | 26 (42.6) | 90 (46.9) | 6 (16.7) |
Pleural TB | 13 (4.5) | 1 (1.6) | 11 (5.7) | 1 (2.8) |
Specimen type (n, %) | ||||
CNB | 191 (66.1) | 48 (78.7) | 117 (60.9) | 26 (72.2) |
Tissue | 98 (33.9) | 13 (21.3) | 75 (39.1) | 10 (27.8) |
Pathological antacid staining (+) (n, %) | 13 (4.5) | 13 (21.3) | 0 (0.0) | 0 (0.0) |
Abbreviations: LNTB, lymph node tuberculosis; HIV, human immunodeficiency virus; LN, lymph node; TB, tuberculosis; CNB, core needle biopsy.